The image below highlights the mechanisms of both GLP-1 and GIP, along with a callout to the newest treatment optiona triple incretin that also includes glucagonexpected to be approved in late 2025 to early 2026
You should check with your healthcare provider or insurance company to determine the cost of Tirzepatide and any potential coverage options available
PlexusDx clinicians monitor side effects during your monthly check-ins and can pause or adjust your tirzepatide dose if constipation significantly impacts quality of life
The approval was supported by data from the Phase III ADRIATIC study, which according to an April 2024 readout hit its primary efficacy endpoints of overall survival and progression-free survival (PFS)
Using it with glutathione lets you address both cellular stress (oxidative) and psychological stress
Every authorization is run and reviewed by a credentialed specialist (RN, PharmD, MD, or AAPC-certified administrator) under HIPAA-compliant conditions with a signed BAA